Refining the optimal chemotherapy regimen for good risk metastatic non.seminomatous germ-cell tumour: a randomized trial of the genito-urinary group of the French Federation of Cancer Centers (GETUG T39BP) - Culine, S; Kerbrat, P; Kramar, A (Ann Oncol, 2007)
et al.